Phase II Study of Epacadostat (INCB024360) With Pembrolizumab (MK3475) in Metastatic or Unresectable Gastroesophageal Junction and Gastric Adenocarcinoma Requiring Paired Biopsies
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Epacadostat (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 19 Sep 2017 Planned End Date changed from 1 Jun 2019 to 1 Sep 2019.
- 19 Sep 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Sep 2019.
- 19 Sep 2017 Status changed from not yet recruiting to recruiting.